Verified current Grant

HEAL Initiative: Non-addictive Analgesic Therapeutics Development [Small Molecules and Biologics] to Treat Pain (UG3/UH3 Clinical Trial Optional)

The purpose of this Notice of Funding Opportunity (NOFO) is to support the preclinical optimization and development of safe, effective, and non-addictive small molecule and biologic therapeutics for the treatment of pain. The goal...

Grant grant Full source details
National Institutes of Health Source published Jun 16, 2026 Verified 1 week ago
✓ 95% verification score · Source: Grants.gov · Always confirm final requirements on the original source.
Complete source information imported The available role or programme description, requirements, benefits and source facts were imported from the public official endpoint and formatted for reading.
DeadlineTue Feb 20 12:00 AM 2029
Fundinggrant

Overview

The purpose of this Notice of Funding Opportunity (NOFO) is to support the preclinical optimization and development of safe, effective, and non-addictive small molecule and biologic therapeutics for the treatment of pain. The goal of the program is to accelerate the advancement of promising early-stage therapeutic candidates and facilitate their readiness for Phase II clinical trials. Applicants must have a promising small molecule or biologic lead candidate for optimization,...

Complete grant details

The purpose of this Notice of Funding Opportunity (NOFO) is to support the preclinical optimization and development of safe, effective, and non-addictive small molecule and biologic therapeutics for the treatment of pain. The goal of the program is to accelerate the advancement of promising early-stage therapeutic candidates and facilitate their readiness for Phase II clinical trials. Applicants must have a promising small molecule or biologic lead candidate for optimization, a strong biological rationale for the proposed approach, and established assays to guide the optimization process. The scope of the program includes lead optimization, early-stage development activities, IND-enabling studies, development of pharmacodynamic and/or target engagement biomarkers, preparation and submission of an Investigational New Drug (IND) application, and Phase I clinical testing. This is a milestone-driven, phased cooperative agreement program that involves active participation by NIH program staff in project planning and ongoing monitoring of research progress.

Eligible applicants Private institutions of higher education; Others (see text field entitled "Additional Information on Eligibility" for clarification); City or township governments; Independent school districts; For profit organizations other than small businesses; Small businesses; Native American tribal organizations (other than Federally recognized tribal governments); Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education; Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education; Public housing authorities/Indian housing authorities; Special district governments; County governments; State governments; Public and State controlled institutions of higher education; Native American tribal governments (Federally recognized)

Refer to Section III. Eligibility Information in the NOFO for additional information on eligibility.Foreign Organizations/International CollaborationsNon-domestic (non-U.S.) Entities (Foreign Organizations) are not eligible to apply.Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply.Foreign components, as defined in the NIH Grants Policy Statement, are not allowed.

Eligibility requirements

Private institutions of higher education; Others (see text field entitled "Additional Information on Eligibility" for clarification); City or township governments; Independent school districts; For profit organizations other than small businesses; Small businesses; Native American tribal organizations (other than Federally recognized tribal governments); Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education; Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education; Public housing authorities/Indian housing authorities; Special district governments; County governments; State governments; Public and State controlled institutions of higher education; Native American tribal governments (Federally recognized)

Refer to Section III. Eligibility Information in the NOFO for additional information on eligibility.Foreign Organizations/International CollaborationsNon-domestic (non-U.S.) Entities (Foreign Organizations) are not eligible to apply.Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply.Foreign components, as defined in the NIH Grants Policy Statement, are not allowed.

Tips for this grant

Practical JobOpportunity guidance. These tips do not replace official rules or create new eligibility requirements.

  1. Check eligibility, funding coverage, study/project level and every required document before investing time in the application.
  2. Prepare transcripts, references, language tests, proposal/motivation statement and proof documents early.
  3. Separate the scholarship deadline from any university/program admission deadline; they may be different.
  4. Treat “fully funded” as a source fact only when the official provider explicitly confirms the covered costs.

Verification notes

Retrieved from the official Grants.gov public API. Applicant types and additional eligibility are reproduced together; program-specific restrictions govern eligibility.

Original authoritative source

JobOpportunity is the discovery and verification layer. Confirm eligibility, dates, salary/funding and application instructions on the original source before submitting anything.

Apply through JobOpportunity →

Browse current JobOpportunity listings from Grants.gov →

Related opportunities

Other current verified records you may want to review.

Grant

University of Sydney awarded gender equality grant

The University of Sydney · Australia

News & opinion false false News false false February false false University of Sydney awarded gender equality grant true true /content/dam/corpor...

Grant

If Scotland’s university funding problem is systemic, the response must be too

Wonkhe Com Opportunities

The Future Framework has measured the pressure on Scottish universities. Vicki Stott sets out how one alliance is testing whether autonomy and sy...

Grant

Clinical and Translational Science Award (UM1 Clinical Trial Optional)

National Institutes of Health

This Notice of Funding Opportunity announcement (NOFO) invites applications for the Clinical and Translational Science Award (CTSA) Program hubs...

Grant

NHLBI Early Phase Clinical Trials for Therapeutics and/or Diagnostics for HLBS Disorders (R33 CT Required)

National Institutes of Health

The objective of this funding opportunity is to support investigator-initiated, phase I clinical trials for diagnostic and therapeutic interventi...

Grant

BRAIN Initiative: Brain Behavior Quantification and Synchronization- Next Generation Sensor Technology Development (U01 Clinical Trial Optional)

National Institutes of Health

This NOFO solicits applications for next generation sensor and bioelectronic device development that will synchronize with brain recordings. The...

Grant

Confirmatory Efficacy Clinical Trials of Non-Pharmacological and Pharmacological Interventions for Mental Disorders (R01 Clinical Trial Required)

National Institutes of Health

Confirmatory Efficacy Clinical Trials of Non-Pharmacological Interventions for Mental Disorders (R01 Clinical Trial Required). As part of NIMH's...

More ways to save

Discover deals, coupons and free courses on our sister site.

Explore DealVorio
Save more with DealVorio: deals, coupons, free courses, apps and books